MetaADEDB 2.0 @ LMMD
Flecainide
(RKXNZRPQSOPPRN-UHFFFAOYSA-N)
Structure
SMILES
O=C(c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F)NCC1CCCCN1.CC(=O)O
Molecular Formula:
C19H24F6N2O5
Molecular Weight:
474.395
Log P:
4.2513
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
96.89
CAS Number(s):
54143-56-5
Synonym(s)
1.
Flecainide
2.
Flecainide Acetate
3.
Apocard
4.
Flecadura
5.
Flecainid-Isis
6.
Flecainide Monoacetate
7.
Flecainide Monoacetate, (+-)-Isomer
8.
Flecainide Monoacetate, (R)-Isomer
9.
Flecainide Monoacetate, (S)-Isomer
10.
Flecainide, (R)-Isomer
11.
Flecainide, (S)-Isomer
12.
Flecainide, 5-HO-N-(6-oxo)-Derivative
13.
Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer
14.
Flecatab
15.
Flécaïne
16.
R818
17.
Tambocor
18.
Flecainid Isis
External Link(s)
MeSHD005424
PubChem Compound46864232
41022
ChEBI5091
CHEMBLCHEMBL1200822
KEGGdr:D00638
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Toxicity to various agentsFAERS: 39US FAERS
2OverdoseFAERS: 24US FAERS
3Accidental overdoseFAERS: 23US FAERS
4Cardiac ArrestFAERS: 23US FAERS
5HypotensionFAERS: 21US FAERS
6TachycardiaFAERS: 19US FAERS
7Atrial FibrillationFAERS: 16US FAERS
8DizzinessFAERS: 14US FAERS
9Drug ineffectiveFAERS: 14US FAERS
10Electrocardiogram abnormalFAERS: 14US FAERS
11BradycardiaFAERS: 13US FAERS
12Suicide attemptFAERS: 11US FAERS
13AstheniaFAERS: 10US FAERS
14Atrial FlutterFAERS: 10US FAERS
15NauseaFAERS: 10US FAERS
16Medication ErrorFAERS: 8US FAERS
17SyncopeFAERS: 8US FAERS
18Completed SuicideFAERS: 7US FAERS
19Acute kidney injuryFAERS: 6US FAERS
20HeadacheFAERS: 6US FAERS
21Incorrect dose administeredFAERS: 6US FAERS
22MalaiseFAERS: 6US FAERS
23SomnolenceFAERS: 6US FAERS
24TachyarrhythmiaFAERS: 6US FAERS
25Chest discomfortFAERS: 5US FAERS
26Drug dispensing errorFAERS: 5US FAERS
27Drug level above therapeuticFAERS: 5US FAERS
28Drug level increasedFAERS: 5US FAERS
29FatigueFAERS: 5US FAERS
30AlkalosisFAERS: 4US FAERS
31AtaxiaFAERS: 4US FAERS
32Blood potassium decreasedFAERS: 4US FAERS
33Chest PainFAERS: 4US FAERS
34Drug exposure during pregnancyFAERS: 4US FAERS
35Drug toxicityFAERS: 4US FAERS
36Electrocardiogram changeFAERS: 4US FAERS
37LethargyFAERS: 4US FAERS
38Metabolic acidosisFAERS: 4US FAERS
39PalpitationsFAERS: 4US FAERS
40Pharmaceutical product complaintFAERS: 4US FAERS
41Product taste abnormalFAERS: 4US FAERS
42Supraventricular tachycardiaFAERS: 4US FAERS
43Accidental exposure to productFAERS: 3US FAERS
44AcidosisFAERS: 3US FAERS
45DysarthriaFAERS: 3US FAERS
46Ejection Fraction DecreasedFAERS: 3US FAERS
47HypoxiaFAERS: 3US FAERS
48Myocardial InfarctionFAERS: 3US FAERS
49Product substitution issueFAERS: 3US FAERS
50Respiratory arrestFAERS: 3US FAERS
51Respiratory distressFAERS: 3US FAERS
52Unresponsive to stimuliFAERS: 3US FAERS
53Ventricular FibrillationFAERS: 3US FAERS
54Wrong technique in drug usage processFAERS: 3US FAERS
55Abdominal discomfortFAERS: 2US FAERS
56Accidental drug intake by childFAERS: 2US FAERS
57Atrioventricular BlockFAERS: 2US FAERS
58Blood potassium increasedFAERS: 2US FAERS
59CyanosisFAERS: 2US FAERS
60FlushingFAERS: 2US FAERS
61General physical health deteriorationFAERS: 2US FAERS
62HypophagiaFAERS: 2US FAERS
63Mental status changesFAERS: 2US FAERS
64Multiple drug overdoseFAERS: 2US FAERS
65Pacing threshold increasedFAERS: 2US FAERS
66Product formulation issueFAERS: 2US FAERS
67Product quality issueFAERS: 2US FAERS
68PruritusFAERS: 2US FAERS
69Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
70Tonic clonic movementsFAERS: 2US FAERS
71TremorFAERS: 2US FAERS
72VomitingFAERS: 2US FAERS
73Wrong technique in product usage processFAERS: 2US FAERS
74Abdominal Compartment SyndromeFAERS: 1US FAERS
75Abdominal massFAERS: 1US FAERS
76Abnormal weight gainFAERS: 1US FAERS
77Accidental exposureFAERS: 1US FAERS
78Accidental underdoseFAERS: 1US FAERS
79Adverse eventFAERS: 1US FAERS
80AlopeciaFAERS: 1US FAERS
81AmnesiaFAERS: 1US FAERS
82AnxietyFAERS: 1US FAERS
83ArteriosclerosisFAERS: 1US FAERS
84ArthralgiaFAERS: 1US FAERS
85AscitesFAERS: 1US FAERS
86Back PainFAERS: 1US FAERS
87Bifascicular blockFAERS: 1US FAERS
88BlindnessFAERS: 1US FAERS
89Blood pH decreasedFAERS: 1US FAERS
90Blood pH increasedFAERS: 1US FAERS
91Blood pressure fluctuationFAERS: 1US FAERS
92Blood pressure immeasurableFAERS: 1US FAERS
93Blood sodium decreasedFAERS: 1US FAERS
94Bronchoalveolar lavage abnormalFAERS: 1US FAERS
95Cardiac FlutterFAERS: 1US FAERS
96CardiotoxicityFAERS: 1US FAERS
97Cerebrovascular accidentFAERS: 1US FAERS
98ChillsFAERS: 1US FAERS
99Choking sensationFAERS: 1US FAERS
100Cold sweatFAERS: 1US FAERS
101Coma scale abnormalFAERS: 1US FAERS
102ConstipationFAERS: 1US FAERS
103DehydrationFAERS: 1US FAERS
104Delusional disorder, persecutory typeFAERS: 1US FAERS
105Depressed moodFAERS: 1US FAERS
106Disease recurrenceFAERS: 1US FAERS
107Drug administration errorFAERS: 1US FAERS
108Drug level changedFAERS: 1US FAERS
109Dry skinFAERS: 1US FAERS
110Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
111Electrocardiogram T wave amplitude increasedFAERS: 1US FAERS
112Electrolyte imbalanceFAERS: 1US FAERS
113ErythemaFAERS: 1US FAERS
114Eye painFAERS: 1US FAERS
115Facial paralysisFAERS: 1US FAERS
116Failure to captureFAERS: 1US FAERS
117Feeling abnormalFAERS: 1US FAERS
118Gluten sensitivityFAERS: 1US FAERS
119HypersensitivityFAERS: 1US FAERS
120HypersomniaFAERS: 1US FAERS
121Impaired driving abilityFAERS: 1US FAERS
122Intentional dose omissionFAERS: 1US FAERS
123Intentional misuseFAERS: 1US FAERS
124Intercepted drug dispensing errorFAERS: 1US FAERS
125Joint swellingFAERS: 1US FAERS
126Long QT SyndromeFAERS: 1US FAERS
127LymphocytosisFAERS: 1US FAERS
128LymphomaFAERS: 1US FAERS
129Medical device complicationFAERS: 1US FAERS
130Memory impairmentFAERS: 1US FAERS
131Metabolic alkalosisFAERS: 1US FAERS
132Multiple drug overdose intentionalFAERS: 1US FAERS
133Muscle strainFAERS: 1US FAERS
134Myocardial necrosisFAERS: 1US FAERS
135Neurological decompensationFAERS: 1US FAERS
136Oxygen saturation immeasurableFAERS: 1US FAERS
137Pacemaker complicationFAERS: 1US FAERS
138Palmar erythemaFAERS: 1US FAERS
139PancreatitisFAERS: 1US FAERS
140Perinatal brain damageFAERS: 1US FAERS
141Plantar erythemaFAERS: 1US FAERS
142PolyneuropathyFAERS: 1US FAERS
143Pre-EclampsiaFAERS: 1US FAERS
144PresyncopeFAERS: 1US FAERS
145Product preparation errorFAERS: 1US FAERS
146PsoriasisFAERS: 1US FAERS
147QRS axis abnormalFAERS: 1US FAERS
148Resting TremorFAERS: 1US FAERS
149Retinal Vein OcclusionFAERS: 1US FAERS
150ShockFAERS: 1US FAERS
151Similar reaction on previous exposure to drugFAERS: 1US FAERS
152Sinus rhythmFAERS: 1US FAERS
153Sudden Cardiac DeathFAERS: 1US FAERS
154SwellingFAERS: 1US FAERS
155ThrombosisFAERS: 1US FAERS
156Urinary tract infectionFAERS: 1US FAERS
157UrticariaFAERS: 1US FAERS
158Vasoplegia syndromeFAERS: 1US FAERS
159Ventricular DysfunctionFAERS: 1US FAERS
160Ventricular arrhythmiaFAERS: 1US FAERS
161Ventricular failureFAERS: 1US FAERS
162Vulvovaginal pruritusFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.